The best programs offering compounded semaglutide and tirzepatide

The short version

Compounded semaglutide and tirzepatide are the same active molecules as Wegovy, Ozempic, and Zepbound — but mixed by 503A pharmacies under prescription rather than manufactured under FDA new-drug approval. The cash-pay savings are real but the regulatory environment is fluid. The FDA declared the semaglutide shortage resolved in October 2024; Lilly has filed coordinated lawsuits against compounded tirzepatide pharmacies. Programs that still offer compounded are operating under clear enforcement risk.

What we considered

• Pharmacy partner stability (recent enforcement history?)
• Transparency on sourcing and regulatory exposure
• Plan B if compounded supply is cut off mid-treatment
• Pricing relative to branded direct-to-consumer (NovoCare, LillyDirect)

Top pick: Mochi Health

Best in category

Mochi Health Compounded GLP-1 specialist with the cleanest pricing in the chart

Starts From

$178/mo incl. medication

Lock-In

Month-to-month

Score

7.6

Read review →

Mochi's flat-priced compounded program is the most transparent in the category about sourcing, pharmacy partners, and regulatory risk. They have publicly addressed pharmacy shutdowns and what their continuity plan is.

Read the full Mochi Health review →

Other strong picks

Found Found has the broadest compounded catalog (semaglutide, tirzepatide, Foundayo orforglipron) but the 6-month non-refundable lock is hostile if supply gets disrupted.

Starts From

$99/mo + med separate

Lock-In

6-month lock-in

Score

6.2

Review →

Noom Med Noom Med only uses compounded for the microdose protocol — branded is the default. This insulates most patients from compounded enforcement risk.

Starts From

$69/mo + med separate

Lock-In

Month-to-month

Score

7.6

Review →

Related